227 related articles for article (PubMed ID: 34681823)
41. Annexin V incorporated into influenza virus particles inhibits gamma interferon signaling and promotes viral replication.
Berri F; Haffar G; Lê VB; Sadewasser A; Paki K; Lina B; Wolff T; Riteau B
J Virol; 2014 Oct; 88(19):11215-28. PubMed ID: 25031344
[TBL] [Abstract][Full Text] [Related]
42. Silent Infection of B and CD8
Castro IA; Jorge DMM; Ferreri LM; Martins RB; Pontelli MC; Jesus BLS; Cardoso RS; Criado MF; Carenzi L; Valera FCP; Tamashiro E; Anselmo-Lima WT; Perez DR; Arruda E
J Virol; 2020 Apr; 94(9):. PubMed ID: 32075928
[TBL] [Abstract][Full Text] [Related]
43. Phosphoproteome Analysis of Cells Infected with Adapted and Nonadapted Influenza A Virus Reveals Novel Pro- and Antiviral Signaling Networks.
Weber A; Dam S; Saul VV; Kuznetsova I; Müller C; Fritz-Wolf K; Becker K; Linne U; Gu H; Stokes MP; Pleschka S; Kracht M; Schmitz ML
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996098
[TBL] [Abstract][Full Text] [Related]
44. MARCH8 inhibits influenza A virus infection by targeting viral M2 protein for ubiquitination-dependent degradation in lysosomes.
Liu X; Xu F; Ren L; Zhao F; Huang Y; Wei L; Wang Y; Wang C; Fan Z; Mei S; Song J; Zhao Z; Cen S; Liang C; Wang J; Guo F
Nat Commun; 2021 Jul; 12(1):4427. PubMed ID: 34285233
[TBL] [Abstract][Full Text] [Related]
45. A Sialylated Voltage-Dependent Ca
Fujioka Y; Nishide S; Ose T; Suzuki T; Kato I; Fukuhara H; Fujioka M; Horiuchi K; Satoh AO; Nepal P; Kashiwagi S; Wang J; Horiguchi M; Sato Y; Paudel S; Nanbo A; Miyazaki T; Hasegawa H; Maenaka K; Ohba Y
Cell Host Microbe; 2018 Jun; 23(6):809-818.e5. PubMed ID: 29779930
[TBL] [Abstract][Full Text] [Related]
46. The role of nuclear NS1 protein in highly pathogenic H5N1 influenza viruses.
Mok BW; Liu H; Chen P; Liu S; Lau SY; Huang X; Liu YC; Wang P; Yuen KY; Chen H
Microbes Infect; 2017 Dec; 19(12):587-596. PubMed ID: 28903072
[TBL] [Abstract][Full Text] [Related]
47. Novel roles of focal adhesion kinase in cytoplasmic entry and replication of influenza A viruses.
Elbahesh H; Cline T; Baranovich T; Govorkova EA; Schultz-Cherry S; Russell CJ
J Virol; 2014 Jun; 88(12):6714-28. PubMed ID: 24696469
[TBL] [Abstract][Full Text] [Related]
48. Collective interactions augment influenza A virus replication in a host-dependent manner.
Phipps KL; Ganti K; Jacobs NT; Lee CY; Carnaccini S; White MC; Manandhar M; Pickett BE; Tan GS; Ferreri LM; Perez DR; Lowen AC
Nat Microbiol; 2020 Sep; 5(9):1158-1169. PubMed ID: 32632248
[TBL] [Abstract][Full Text] [Related]
49. Phosphatidylinositol-3-kinase (PI3K) is activated by influenza virus vRNA via the pathogen pattern receptor Rig-I to promote efficient type I interferon production.
Hrincius ER; Dierkes R; Anhlan D; Wixler V; Ludwig S; Ehrhardt C
Cell Microbiol; 2011 Dec; 13(12):1907-19. PubMed ID: 21899695
[TBL] [Abstract][Full Text] [Related]
50. A Conserved Residue, Tyrosine (Y) 84, in H5N1 Influenza A Virus NS1 Regulates IFN Signaling Responses to Enhance Viral Infection.
Wang BX; Wei L; Kotra LP; Brown EG; Fish EN
Viruses; 2017 May; 9(5):. PubMed ID: 28498306
[TBL] [Abstract][Full Text] [Related]
51. Inhibition effects of novel polyketide compound PPQ-B against influenza A virus replication by interfering with the cellular EGFR pathway.
Wang M; Wang S; Wang W; Wang Y; Wang H; Zhu W
Antiviral Res; 2017 Jul; 143():74-84. PubMed ID: 28414053
[TBL] [Abstract][Full Text] [Related]
52. Influenza A virus utilizes a suboptimal Kozak sequence to fine-tune virus replication and host response.
Wang J; Peng Y; Zhao L; Cao M; Hung T; Deng T
J Gen Virol; 2015 Apr; 96(Pt 4):756-766. PubMed ID: 25519170
[TBL] [Abstract][Full Text] [Related]
53. Unexpected Functional Divergence of Bat Influenza Virus NS1 Proteins.
Turkington HL; Juozapaitis M; Tsolakos N; Corrales-Aguilar E; Schwemmle M; Hale BG
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237829
[TBL] [Abstract][Full Text] [Related]
54. Selective and ATP-competitive kinesin KIF18A inhibitor suppresses the replication of influenza A virus.
Cho YB; Hong S; Kang KW; Kang JH; Lee SM; Seo YJ
J Cell Mol Med; 2020 May; 24(10):5463-5475. PubMed ID: 32253833
[TBL] [Abstract][Full Text] [Related]
55. Infection of Mouse Macrophages by Seasonal Influenza Viruses Can Be Restricted at the Level of Virus Entry and at a Late Stage in the Virus Life Cycle.
Londrigan SL; Short KR; Ma J; Gillespie L; Rockman SP; Brooks AG; Reading PC
J Virol; 2015 Dec; 89(24):12319-29. PubMed ID: 26423941
[TBL] [Abstract][Full Text] [Related]
56. Robust expression of p27Kip1 induced by viral infection is critical for antiviral innate immunity.
Rai KR; Chen B; Zhao Z; Chen Y; Hu J; Liu S; Maarouf M; Li Y; Xiao M; Liao Y; Chen JL
Cell Microbiol; 2020 Nov; 22(11):e13242. PubMed ID: 32596986
[TBL] [Abstract][Full Text] [Related]
57. Equine Mx1 Restricts Influenza A Virus Replication by Targeting at Distinct Site of its Nucleoprotein.
Fatima U; Zhang Z; Zhang H; Wang XF; Xu L; Chu X; Ji S; Wang X
Viruses; 2019 Dec; 11(12):. PubMed ID: 31810278
[TBL] [Abstract][Full Text] [Related]
58. Influenza A Virus Uses PSMA2 for Downregulation of the NRF2-Mediated Oxidative Stress Response.
Rashid MU; Gao A; Coombs KM
J Virol; 2022 Mar; 96(5):e0199021. PubMed ID: 35019712
[TBL] [Abstract][Full Text] [Related]
59. Inhibition Effects and Mechanisms of Marine Compound Mycophenolic Acid Methyl Ester against Influenza A Virus.
Wang Z; Sun L; Zhao H; Sow MD; Zhang Y; Wang W
Mar Drugs; 2024 Apr; 22(5):. PubMed ID: 38786581
[TBL] [Abstract][Full Text] [Related]
60. Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy.
Pelz L; Rüdiger D; Dogra T; Alnaji FG; Genzel Y; Brooke CB; Kupke SY; Reichl U
J Virol; 2021 Nov; 95(24):e0117421. PubMed ID: 34550771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
